For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of East Anglia

Return to search Previous output Next output
Output 46 of 55 in the submission
Article title

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: Quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Type
D - Journal article
Title of journal
The Lancet Oncology
Article number
-
Volume number
14
Issue number
3
First page of article
236
ISSN of journal
14702045
Year of publication
2013
URL
-
Number of additional authors
18
Additional information

I have made a substantial contribution to the conception and design of the study

I have made a substantial contribution to the organisation of the conduct of the study

I have made a substantial contribution to carrying out the study (including acquisition of study data)

I have made a substantial contribution to analysis and interpretation of study data

I have helped draft the output

I have critiqued the output for important intellectual content

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
7
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-